The Center for Cancer Genomics (CCG) facilitates the design, execution, and analyses of cancer research projects through collaborations with investigators. We continually develop and adapt new technologies to accelerate discoveries in cancer genomics and apply these discoveries to improve personalized patient care.CCG leverages a multitude of existing and new capabilities for comprehensive genomic characterization, computational analysis, and technology development. It brings together Dana-Farber Cancer Institute (DFCI) and Brigham and Women?s Hospital (BWH) resources to pioneer new approaches for tissue biopsies, with the goal of facilitating the generation and clinical interpretation of tumor molecular data from clinical trials. CCG integrates and coordinates